Related Experiment Video
Updated: Jan 30, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Rotavirus gastroenteritis in Indian children < 5 years hospitalized for diarrhoea, 2012 to 2016
Sidhartha Giri1, Nayana P Nair1, Ann Mathew2
1Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Insights
Rotavirus gastroenteritis is common in Indian children under five. Pre-vaccine surveillance revealed diverse rotavirus genotypes, essential for monitoring the oral rotavirus vaccine
Area of Science:
- Public Health
- Virology
- Pediatrics
Background:
- The Indian government introduced the oral rotavirus vaccine (ROTAVAC) in 2016, expanding its reach in 2017.
- This study presents four years of data on rotavirus gastroenteritis in hospitalized children under five years old before the vaccine's introduction.
Purpose of the Study:
- To establish pre-vaccine baseline data on rotavirus gastroenteritis prevalence and circulating genotypes in India.
- To provide essential data for evaluating the impact of the oral rotavirus vaccine post-introduction.
Main Methods:
- Hospitalized children under five with diarrhea were recruited from seven sites in southern and northern India (July 2012 - June 2016).
- Stool samples were analyzed for rotavirus using enzyme immunoassay (EIA).
- EIA-positive samples underwent genotyping via reverse-transcription polymerase chain reaction.
Main Results:
- Rotavirus was detected in 35.5% (2069/5834) of stool samples.
- The most prevalent genotypes in southern India were G1P[8] (56.3%), G2P[4] (9.1%), and G9P[4] (7.6%).
- In northern India, common genotypes included G1P[8] (36%), G9P[4] (11.4%), and G2P[4] (11.2%).
Conclusions:
- Rotavirus gastroenteritis exhibits high prevalence and significant genotypic diversity across India.
- Pre-vaccine surveillance data is crucial for assessing the future impact of the rotavirus vaccine on disease burden and circulating strains.
Background:
In 2016, the Government of India introduced the oral rotavirus vaccine (ROTAVAC, Bharat Biotech, India) in 4 states of India as part of the Universal Immunization Programme, and expanded to 5 more states in 2017. We report four years of data on rotavirus gastroenteritis in hospitalized children < 5 years of age prior to vaccine introduction.
Methods:
Children from 7 sites in southern and northern India hospitalized for diarrhoea were recruited between July 2012 and June 2016. Stool samples were screened for rotavirus using enzyme immunoassay (EIA). The EIA positive samples were genotyped by reverse-transcription polymerase chain reaction.
Results:
Of the 5834 samples from the 7 sites, 2069 (35.5%) were positive for rotavirus by EIA. Genotyping was performed for 2010 (97.1%) samples. G1P[8](56.3%), G2P[4](9.1%), G9P[4](7.6%), G9P[8](4.2%), and G12P[6](3.7%) were the common genotypes in southern India and G1P[8](36%), G9P[4](11.4%), G2P[4](11.2%), G12P[6](8.4%), and G3P[8](5.9%) in northern India.
Conclusions:
The study highlights the high prevalence of rotavirus gastroenteritis in India and the diversity of rotavirus genotypes across different geographical regions. Pre- vaccine surveillance data is necessary to evaluate the potential change in admission rates for gastroenteritis and circulating rotavirus genotypes after vaccine introduction, thus assessing impact.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Drug Dosing: Infants and Children
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Pedigree Analysis

